Cvs Health (CVS) Cash from Financing Activities (2009 - 2026)

Cvs Health has reported Cash from Financing Activities for 18 years, with the latest figure at -$2.3 billion in Q1 2026.

• For the quarter ending Q1 2026, Cash from Financing Activities rose 0.6% year-over-year to -$2.3 billion; the trailing twelve-month figure through Mar 2026 stood at -$4.9 billion (down 119.91% YoY), and the FY2025 full-year result was -$4.9 billion, down 335.24% from the prior year.
• Cash from Financing Activities for Q1 2026 stood at -$2.3 billion, down from -$2.0 billion in the prior quarter.
• The five-year high for Cash from Financing Activities was $3.6 billion in Q2 2023, with the low at -$3.2 billion in Q3 2022.
• Historically, Cash from Financing Activities has averaged -$954.5 million across 5 years, with a median of -$1.6 billion in 2024.
• Annual changes were most pronounced in 2023 — Cash from Financing Activities jumped 247.34% — and 2025, when it slumped 571.46%.
• Cvs Health's Cash from Financing Activities stood at -$2.2 billion in 2022, then surged by 55.56% to -$972.0 million in 2023, then soared by 144.34% to $431.0 million in 2024, then tumbled by 571.46% to -$2.0 billion in 2025, then decreased by 14.07% to -$2.3 billion in 2026.
• The last three Cash from Financing Activities figures came in at -$2.3 billion (Q1 2026), -$2.0 billion (Q4 2025), and -$1.4 billion (Q3 2025), per Business Quant data.